NYSE:MMS - MAXIMUS Stock Price, Forecast & News

MAXIMUS trades on the New York Stock Exchange (NYSE) under the ticker symbol "MMS."

MAXIMUS announced a quarterly dividend on Wednesday, January 8th. Stockholders of record on Friday, February 14th will be given a dividend of $0.28 per share on Friday, February 28th. This represents a $1.12 dividend on an annualized basis and a dividend yield of 1.50%. The ex-dividend date of this dividend is Thursday, February 13th. View MAXIMUS's Dividend History.

MAXIMUS declared that its board has initiated a share repurchase program on Monday, June 25th 2018, which allows the company to repurchase $200,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization allows the company to buy up to 4.9% of its stock through open market purchases. Stock repurchase programs are often an indication that the company's board believes its shares are undervalued.

MAXIMUS, Inc. (NYSE:MMS) released its earnings results on Tuesday, November, 19th. The health services provider reported $0.93 earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of $0.94 by $0.01. The health services provider had revenue of $754.97 million for the quarter, compared to analysts' expectations of $756.40 million. MAXIMUS had a net margin of 8.34% and a return on equity of 21.09%. The business's revenue was up 35.2% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.71 EPS. View MAXIMUS's Earnings History.

MAXIMUS is scheduled to release their next quarterly earnings announcement on Thursday, February 6th 2020. View Earnings Estimates for MAXIMUS.

MAXIMUS updated its FY 2020 Pre-Market earnings guidance on Monday, November, 25th. The company provided EPS guidance of $$3.95-4.15 for the period, compared to the Thomson Reuters consensus EPS estimate of $$4.07. The company issued revenue guidance of $$3.15-3.3 billion, compared to the consensus revenue estimate of $$3.17 billion.

2 Wall Street analysts have issued 12 month target prices for MAXIMUS's shares. Their forecasts range from $77.00 to $81.00. On average, they expect MAXIMUS's share price to reach $79.00 in the next year. This suggests a possible upside of 6.1% from the stock's current price. View Analyst Price Targets for MAXIMUS.

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for MAXIMUS in the last year. There are currently 2 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for MAXIMUS.

Headlines about MMS stock have trended extremely negative this week, according to InfoTrie. InfoTrie identifies positive and negative media coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. MAXIMUS earned a news impact score of -4.0 on InfoTrie's scale. They also assigned news coverage about the health services provider a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the stock's share price in the next few days. View News Stories for MAXIMUS.

MAXIMUS saw a increase in short interest during the month of December. As of December 31st, there was short interest totalling 1,670,000 shares, an increase of 6.4% from the December 15th total of 1,570,000 shares. Based on an average daily volume of 393,600 shares, the short-interest ratio is presently 4.2 days. Approximately 2.6% of the shares of the company are sold short. View MAXIMUS's Current Options Chain.

Some companies that are related to MAXIMUS include Visa (V), Mastercard (MA), Fidelity National Information Servcs (FIS), Fiserv (FISV), Automatic Data Processing (ADP), Global Payments (GPN), Worldpay (WP), Paychex (PAYX), FleetCor Technologies (FLT), Total System Services (TSS), Broadridge Financial Solutions (BR), Jack Henry & Associates (JKHY), The Western Union (WU), WEX (WEX) and Euronet Worldwide (EEFT).

Based on aggregate information from My MarketBeat watchlists, some companies that other MAXIMUS investors own include Altria Group (MO), Tesla (TSLA), Bank of America (BAC), Southwest Airlines (LUV), Wells Fargo & Co (WFC), Gilead Sciences (GILD), AbbVie (ABBV), Bristol-Myers Squibb (BMY), Dominion Energy (D) and New Oriental Education & Tech Grp (EDU).

MAXIMUS's stock is owned by a number of of institutional and retail investors. Top institutional investors include Riverbridge Partners LLC (0.73%), West Coast Financial LLC (0.16%), Assenagon Asset Management S.A. (0.08%), Nisa Investment Advisors LLC (0.06%), Louisiana State Employees Retirement System (0.02%) and Bowling Portfolio Management LLC (0.02%). Company insiders that own MAXIMUS stock include David Francis, Mark Andrekovich, Paul R Lederer, Raymond B Ruddy, Richard A Montoni, Russell A Beliveau and Thomas D Romeo. View Institutional Ownership Trends for MAXIMUS.

MMS stock was sold by a variety of institutional investors in the last quarter, including Riverbridge Partners LLC, Bowling Portfolio Management LLC, Nisa Investment Advisors LLC, State of Alaska Department of Revenue, West Coast Financial LLC and Verus Financial Partners Inc.. Company insiders that have sold MAXIMUS company stock in the last year include David Francis, Paul R Lederer, Raymond B Ruddy, Richard A Montoni, Russell A Beliveau and Thomas D Romeo. View Insider Buying and Selling for MAXIMUS.

MMS stock was purchased by a variety of institutional investors in the last quarter, including Assenagon Asset Management S.A., Zeke Capital Advisors LLC, Private Trust Co. NA, Campbell & CO Investment Adviser LLC, First National Bank of Omaha, Larson Financial Group LLC, Camelot Portfolios LLC and Zurcher Kantonalbank Zurich Cantonalbank . View Insider Buying and Selling for MAXIMUS.

Shares of MMS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of MMS stock can currently be purchased for approximately $74.43.

MAXIMUS has a market capitalization of $4.76 billion and generates $2.89 billion in revenue each year. The health services provider earns $240.82 million in net income (profit) each year or $3.72 on an earnings per share basis. MAXIMUS employs 29,600 workers across the globe.View Additional Information About MAXIMUS.

The official website for MAXIMUS is http://www.maximus.com/.

MAXIMUS's mailing address is 1891 METRO CENTER DRIVE, RESTON VA, 20190. The health services provider can be reached via phone at 703-251-8500 or via email at [email protected]